life scienc tool diagnost dental data research pack
week march
report limit sole use client wolf research pleas refer disclosur section locat end report analyst
certif disclosur import disclosur pleas go www wolferesearch com/disclosur write us wolf research llc
dental field check compani sentiment
dental practic go lockdown us europ time dig mean near
term think longer term recess scenario countri practic shift
emerg procedur mani countri see slide expect dental practic see impact practic
revenu per week practic close teeth dont heal volum come back
open question volum trend relat region includ us spain
china/germani payment either self-pay employment-driven make govern polici ala cobra
insur import watch length movement restrict impact labor forc critic
healthcar experi china roughli shutdown reason guid
us/eu experi term time intens lower suggest volum
recov june even back half may pressur strong know
assum lot viru act come day defer lost volum
rememb dental care outsid china far less hospital-centr therefor less tie hc system upheav
item watch unemploy practic shutdown discretionari spend outsid healthcar
deck nation guidelin updat practic closur compani commentari dentist call takeaway recess
cycl analysi key lead indic dental spend valuat updat
lot pain price much pain unless sustain unemploy spike
 discount dental ntm price-to-earnings premium median price-to-earnings premium healthcar price-to-earnings dental field check practic go lockdown
recent call takeaway recent caught us base dentist gaug impact dental
practic due guidanc ada cdc
call dental practic indic near term follow ada cdc guidelin restrict
procedur emerg care previous schedul restorative/impl case region impact expect
somewhat differ dental practic discret case treat spread
vari across countri us clinician view ada/cdc guidelin suggest rule unlik
china flexibl regard oper sens impact volum
us immateri last week quarter materi
impact like region
dentist talk indic practic procedur could defer prohibit
non-emerg procedur impact revenu would somewhat lower impact emerg
procedur typic higher averag price per visit
view practic closur last may
would impli backlog visit summer dentist speak feel comfort
address end summer schedul typic lighter deferr hygien visit like drive higher
volum higher acuiti make deferr care net neutral posit year
earn impact mayb smaller suggest even near term hear report pre-buy
anticip ship limit includ endo implant suppli higher margin moreov endo
implant volum may hold better other high margin high acuiti
revenu impact near term could per week mainli lower margin item
temporari key still employ data summer beyond
dental co see china come back shutdown dmmanag
view corpor pull guidanc shortli last convers
provid help perspect
even pull guidanc clear near-term orthodont guidelin like see
substanti complianc mean near term pressur volum like surg even function well
aesthet ortho case non-emerg larg major case on-line train scale support futur
momentum compani abl run treatment planning/manufactur global divers facil base
algn guidanc pull unspecif unsurpris expect near-term shutdown medium-term
pressur key watch employ discretionari trend
apac back comfort china/asia volum return encourag dental
broader devic china march recoveri stori back apac global
confid diversifi suppli chain flexibl schedul curb suppli concern even
sirona bensheim site critic schedul enabl product respect social distanc
europ tough differ dental care europ often govern fund govern
hospit like china expect basic care remain case apac aesthetic/deferr case push
later year tougher environ implant ortho specialti area
us eu
seem extern consensu care pressur month intern sentiment
dental provid independ profit motiv
save lever get pull whether like dental trade show per year attend
key vendor larg player expenditur plan
event larg number key cost off-set major diversifi like drive least
ebitda save year
china recoveri sharp pressur per week lower region cost off-set
market item sizabl
dental societi practic closur come us/eu fade apac
expect sharp impact week month us/eu china recov harder
orthodont near term less acut china assum unemploy surg
countryrestrictiontimingimplicationunit statesadacallsforhalttoelectivecar includingcleaningsandradiograph non-emergencyorthodont extractionofasymptomat teeth fill asymptomat caviti aestheticsstart march acut ortho limit impact endo modest restor expect deferr summercanadanoguidefromthecanadiandentalassoci ontarioandquebecsocietiesencouragedelaystoelectiveandpreventivethrough end marchpressur acut ortho limit impact endo modest restor expect deferr summeraustralia new zealandaustraliaandnewzealandadviseelevatedinfectioncontrol symptom screen call case deferr nomin impact italyal movement restrictedthrough april laterhighli constrainingunit kingdomcutroutinecarefor vulnerablegroup consolidatingemerg care april-junemateri headwinddenmarkdelay non-emerg care monthson longer time periodsnetherlandssuspend routin careat least april dental volumesportugalemerg care april laterneg dental volumesaustriano suggest practic closuresmodestli positivechinadent clinic selec reopen february/march late marchcompani call normal volum return dental updat get readi recess cycl data
soon see impact crisi data tell big impact
come month
servic spendingy/i medic dental equip manufacturingy/i stack spend usy/i stack labor market index orthodont watch discretionari trend
come month consum behavior key indic sdc
key line watch histori show cyclic substanti
spend proxi usy/i stack watch export apachong board high incom us con conf high-incom consum confid y/i average chang indexdent index yoy global ppp growth rh yoy index growth lh player product cycl histor rel low
multipl heavi pressur mid-pack cycl
compani data factset price wolf research
price-to-earnings premium ical etf p/edent price-to-earnings premium devic price-to-earnings vs dental distributor price-to-earnings flight safeti inflat multipl vs /nvst
manufactur under-perform rel meaning
compani data factset price wolf research
price-to-earnings premium dental averag median price-to-earnings premium dental averag median price-to-earnings premium medic etf price-to-earnings median price-to-earnings premium medic etf price-to-earnings medianmedian sinc ipo bonu stale consensu look closer all-tim low
valuat jump impli expect major recess
click request question list life scienc tool dental
hot link favorit read last week
link relat commentari
sonic healthcar withdraw guidanc due
risk diagnost test
risk state trail implement
coronaviru deadli itali
compani data factset price wolf research
lack reliabl data issu track coronaviru
peopl carri coronaviru show symptom
could high third case
american hospit capac project need
price-to-earnings premium price-to-earnings premium growth median price-to-earnings link full list life scienc tool research note model
link note
link
view agil growth expect look
alway china china china evid
agil share gain vs competitor guidanc
reason account slower tool sector growth
result point moder china optim structur
off-set compani specif driver
stori pt
heavi revenu growth japan previou
vat rise identifi tool name saw
displac fiscal chang
weak nano qtr weak semi japan demand good
news new research ms/uhf instal cut pt
steadi stream water investor event
analyst day view growth outlook water
model updat ge dental note revis
model portfolio chang ahead
clinic strategi imper walk
potenti revenu boon ilmn panel
util acceler consum spend
consolid larger lab
life scienc tool preview cut valuat
estim talk reason pt
ep cut gtmi read-out july/august
posit go
learn pittsburgh lab visit travel
pki rep test lab find personnel hardwar remain
bottleneck vanadi reliabl remain concern
emerg macro trend new pittsburgh lab
deal process unsuccess pt given
announc board termin
recent acquisit
discuss potenti acquiror revert standard
valuat method prior year-end pt
move rate move rate news
updat model acquisit
publish updat model
acquir believ
longer trade fundament
ceo meet share gain
takeaway ceo marc casper ir vice-president
rafael tajeda lunch wolf buy-sid
steadi trend posit watch capital-expenditure highlight
deceler attract growth bioprocess suit
indic
counter-pmi find cyclic categori continu
adjust tool dental pt favor
slow organ revenu bridg point
balanc sheet cash convers view
acceler modifi tool growth outlook
bifurc cyclic cyclic exposur
tools/dent rel attract last
perceiv insul washington dynam hc
ls tool ponder exposur matrix take
tactic look tool dental compani exposur
recent return quantifi risk
tool china outlook updat data china slow
tool compani includ data china govern
spend tax receipt
link full list dental research note model
link note
link
look oversold overview valuat
project growth cover sdc
china tariff dtc
algn acq exocad shrewd posit move
integr clinician softwar potenti improv sale
access reiter lrp guid
dental hsic/pdco dental unexpect twist
manag meet takeaway
ftc found part conspiraci refus
recent visit hq comfort
discount group serv small dental practic
dental industri overview detail look dental
key data point practic consolid exposur
diverg reiter underweight sector
flesh expect
ahead ex-item review
result reflect improv trend consum
strong growth primescan guidanc
impact
initi initi outperform pt initi
highest impli upsid coverag strong
investor event ramp spark clear align
launch timelin new intraor scanner updat
greater ny dental meet note convers
gp summit review event
manag team privat public
gener practic dentist includ potenti
compani greater ny dental meet
autom case selection/planning/follow help gp
dentist compet dtc offer
orthodontist survey survey
orthodontist dentist indic limit clear
align share shift compar may survey
dental industri survey survey dentist
dental offic indic risk hsic/pdco relat
shift amzn/region player
upgrad op upgrad outperform
estim reflect move pd
rais pt posit oper
leverag compani limit competit
sdc entri ortho suppli market note sdc
bridg provid detail revenu build
announc enter wholesal clear align
estim impact primescan
market sell dentist ortho
primemil
compani data factset price wolf research
targetorganicdebt /compani nametickerratingcurr pricefor ye market floatday ex small scienc tool wolf lst ex small wr life scienc tool dental recommendationsshort interestp/efcf yieldev/salesev/ebitda life scienc tool price target
compani data factset price wolf research
compani data factset price wolf research
compound-annual-growth-rate ebitda compound-annual-growth-rate ev-ebitda vs estimate ebitda compound-annual-growth-rate tool yieldfcf compound-annual-growth-rate compound-annual-growth-rate cap healthcar price-to-earnings vs ep compound-annual-growth-rate valuat tool compani rel tangenti industri
compani data factset price wolf research
price-to-earnings premium healthcar price-to-earnings premium devic price-to-earnings premium industri median ev/ebitda premium ev/ebitda short interest trend
note short interest share float decemb short interest spike potenti due trade dynam around
wolf research factset price
tabl content
note model link
valuat price target
revenu growth end market exposur
tool compani growth rate sector
compani data factset price wolf research
stack accel/decel organ growth momentum estimateswolfeensu wgtd diff wgtd diff vs toolsdentaltickercurr priceratingpric chang price targetensu price vs wolf differ vs current estimate epswolf epscurrentdiffer vs current estimate ensu saleswolf organ ebit margin expans vs average expansionwolfeensusl tool wgtd yr average dental wgtd average accel toolsdent life scienc tool tough macro hit cyclic sm end market exposur
expect macro-driven slowdown drug price small molecul increment risk
note fast-growth exposur includ estim total revenu exposur biotech manufactur academ lab regul dx static includ
exposur sm qa/qc gov lab cyclic end market
global end tool chang indexyoy chang organ revenu composit yoy gtmi vs composit yoy org revenue org revenue stack org revenue comp indexstack pf forg ls pkiqgentmowatexposur fast-growth vs cyclical-growth end market growth exposurecycl exposurenet exposur life scienc tool end market exposur detail
total life scienceacademic/gov tpharmatot regulateddiagnosticsfoodenvironmentalforensics/othertot cyclicalenergy/ chemdiagnosticsfoodenvironmentaloth pharma salescro/cdmo salesr mfg small mol qa/qcsoftware/ servicessmal mol biotech/ larg pf ge wgtd exposur sub-categorytot cyclic saleschemicalsoil gasfoodenv semiconductorsgeneral/oth exposur sub-categoryacademic/govern split bioprocess
categori organ chang org revenue qtli yoy chang mthli yoy chang vs yoy chang org revenue bioprocessorg revenue stack revenu growthyoy revenu stack revenu growthbioprocess stack capital-expenditure combin spend trail quarter yoy stackedbioprocess stack bioprocess bioprocess vs lab capital-expenditure trend
cdmo guid capital-expenditure wuxi biolog lonza guid capital-expenditure acceler
follow normal samsung siegfri cut capital-expenditure thru recipharm msd-flat
visibl bioprocess cycl correl comp-adjust average capital-expenditure growth org weight revenu
growth bioprocess set find lag relationship btw cycl suggest decel revenue
note group includ lonza wuxi siegfri recipharma samsung biolog bioprocess group includ
pall merck kgaa
growth capital-expenditure capital-expenditure trend diverg ex-wuxitop capital-expenditure growthtop group enu growthcomp-adjust capital-expenditure growthcomp-adjust capital-expenditure growth inc wuxi vs bioprocess org revenue growthorg bioprocess revenue growthtop capital-expenditure group enu growthcomp-adjust capital-expenditure growthcomp-adjust capital-expenditure growth ex-wuxi vs bioprocess org revenue growthbioprocess org enu growthyoy top capital-expenditure growth group enu growth group enu growthtop revenu growth ex-siegfriedv bioprocess revenu growthbioprocess org revenue growthtop growth ex-sfforecast industri capital-expenditure trend continu slide
move combin capital-expenditure chang org revenue qtli yoy chang mthli yoy chang vs yoy chang org revenue industri aggreg org revenue stack average industri product growth chem pressur price volum persist
growth faichina raw chem materialschina organictickerstack growth growth guideaccel/decel chang index european product price industri indic
note quarter organ growth comparison in-lin agil fiscal year begin earli
compani data factset feder reserv bank st loui wolf research
price chang index industri product us primari organ growth agil lsag organ growth vs oil futur commod price agil lsag org growthagil lsag stack org growthwti crude oil futur lh global price index commod capital-expenditure nam capexrow capexworld capexdril complet pharma posit biolog remain prefer
chang org revenue qtli yoy chang mthli yoy chang vs yoy chang org revenue pharmaorg revenue stack coverag pharma organ growthyoystack us ipo vc volum mn vc fund mnu ipo volum y/i changetot us rx mm total us rx volumetot us rx volumeu yoy salesgrowthint yoy salesgrowth pharma deflationari pressur persist small molecul
inflat proxi yoy chang month move average growth drug/biolog approv trendbla approvalsnda month anda capital-expenditure combin spend trail quarter y/i stackedbioprocess stack bioprocess pharma real-tim macro indic inflect neg
pharma confid proxi next month proxi european pharmaceut constitu chang volum proxi index non-prescript medicin us labor proxi us yoy diagnost
us medic laboratori activ us -stack us analyt laboratori activ us chang org revenue qtli yoy chang mthli yoy chang vs yoy chang org revenue dxorg revenue stack average chang org revenue qtli yoy chang mthli yoy chang vs yoy chang org revenue molecular dxorg revenue stack average diagnost
market organ growthweight averag organ growth averag diagnost organ growthweight averag organ growth averag inc becton dickinson co biomerieux sabio-rad laboratori inc cepheid inc danah corp diasorin grifol sahologicluminex corp miraca ivdqiagen quidel corp rochesiemen healthineerssysmex corp total diagnost market share shift dxothertot dx market share vs mol dx market share ivd market sharetot mol dx share academ govern
academic/govt organ chang org revenue qtli yoy chang mthli yoy chang vs yoy chang org revenue acad-govorg revenue stack fund disburs gov spend yr yr china coronaviru impact tool
note ncov confirm case updat use guidanc ncov-rel manufactur disrupt
call assumpt ncov impact assum impacttick impli drag china sales/weekchina exposureimpli full quarter impact total sale week assum h-wind compani china sale china sale h-wind week china sale mn drag china cumul confirm casesconfirm case mainlandchina lh confirm case ex-mainland china chang china org revenu -tool chang gov spendchina life scienc composit gov spend growth vs yoy china tool org revenu growthtool china gov ls spend ls gov spend china gov revenu growth vs spend growthchina gov spend growthgov revenu growthl gov spend growthtariff revenu growth china
credit -medium/long-term yoy pharma export valu proxi yoy chang org revenue qtli yoy chang mthli yoy chang vs yoy chang org revenue coverag chinaorg revenue stack gov spend yr yr disclosur section
